Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

for
Acute Myeloid Leukemia, Essential Thrombocythemia,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT04282187

Phase2, Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Seattle WA, Vancouver, Calgary, Salt Lake City UT,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

Collection of Tissue Samples for Cancer Research

for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Seattle WA, Iowa City IA, St Louis MO, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT00900198

Recruiting

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: Seattle WA, Duarte CA, Dallas TX, Chicago IL,
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase1, Phase2, Recruiting

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

for
Non-Malignant Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 49

Code: NCT04083183

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Seattle WA, Portland OR, Los Angeles CA, Aurora CO,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy

for
Cytokine Release Syndrome
Location: Seattle WA, Orange CA, Pittsburgh PA, Augusta GA,
Sponsor: CytoAgents, Inc.

Sex: All

Age: 18+

Code: NCT05905328

Phase1, Phase2, Recruiting

A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

for
Carcinoma, Non-Small-Cell Lung
Location: Seattle WA, Portland OR, Anchorage AK, Milwaukee WI,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06855771

Phase2, Recruiting

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

for
Chronic Myelogenous Leukemia
Location: Seattle WA, Houston TX
Sponsor: Shenzhen TargetRx, Inc.

Sex: All

Age: 18+

Code: NCT06088888

Phase1, Recruiting

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

for
Adenoid Cystic Carcinoma, Colorectal Cancer
Location: Seattle WA, St Louis MO, Ann Arbor MI, Houston TX,
Sponsor: Rgenta Therapeutics Inc

Sex: All

Age: 18+

Code: NCT06462183

Phase1, Recruiting

Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Female

Age: 18+

Code: NCT05930483

Recruiting

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Seattle WA, Los Angeles CA, Irvine CA, Charlotte NC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06697197

Phase1, Phase2, Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: Seattle WA, Portland OR, Salt Lake City UT, Duarte CA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Seattle WA, Los Angeles CA, Madison WI, Houston TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06625593

Phase1, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Seattle WA, Edmonton, Sacramento CA, Stanford CA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase1, Recruiting

A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas

for
Retroperitoneal Sarcoma, Liposarcoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06025747

Phase1, Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Seattle WA, Salt Lake City UT, Stanford CA, La Jolla CA,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase1, Recruiting

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for
Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer,
Location: Seattle WA, San Francisco CA, Fairway KS, Houston TX,
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT06281678

Phase2, Recruiting

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT06039371

Phase2, Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Seattle WA, Vancouver WA, Boulder CO, Orange CA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase3, Recruiting